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The aim of this thesis was to study the preparation of three dimensional load-
bearing bioactive hybrid materials for orthopedic applications. The application area 
is interbody cage in spinal fusion. The load-bearing component in the material is 
electron beam melting (EBM) manufactured titanium alloy (TiAl6V4) mesh, whereas 
the bioactive component was either crushed bone graft or composite made of 
biodegradable polymer and bioactive glass (BAG). Polymers were made porous to 
allow bone ingrowth. 
 
In this study, porous structures were made of thermoplastic and photocrosslinkable 
polycaprolactone (PCL). Three methods were used to prepare porous structures of 
thermoplastic PCL: freeze drying, freeze extraction and dipping. Porous structure of 
freeze extraction samples was determined using micro computed tomography (μCT) 
and scanning electron microscope. Pores were interconnected and porosity was 66-
76 %. However, the pore size was probably too small for cell ingrowth. For 
photocorsslinking of PCL, methacrylated PCL oligomer was synthetized and mixed 
with BAG and porogen agent salt. Titanium alloy mesh was immersed in the mixture 
and the polymer was photocrosslinked. 
 
Compression strength at break was determined for photocrosslinked samples and 
trabecular bone samples. Compression strength at break (8 MPa) and compressive 
modulus (0.2 GPa) for titanium meshes were close to literature values of trabecular 
bone (2-22 MPa and 0.2-1.9 GPa, respectively). Therefore, the hybrid material is 
probably suitable for interbody cage fusion, because vertebrae are trabecular bone. 
However, cortical bone has much higher compression strength values at literature 
(100-230 MPa). Therefore the materials cannot be used in cortical bone 
applications.  
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Tiivistelmä 
Diplomityön tavoitteena oli tutkia kolmiulotteisten kuormaa kantavien bioaktiivisten 
hybridimateriaalien valmistusta ortopedisiin sovelluksiin. Sovelluskohteeksi valittiin 
välilevyimplantti spinaalifuusioon. Kuormaa kantavana komponenttina materiaalissa 
toimi EBM -menetelmällä valmistettu titaaniseosverkko (TiAl6V4), kun taas bioaktiivisena 
komponenttina toimi joko pankkiluumurska tai biohajoavan polymeerin ja bioaktiivisen 
lasin muodostama komposiitti. Polymeeri huokoistettiin solujen sisään kasvun 
mahdollistamiseksi. 
 
Tutkimuksessa valmistettiin huokoisia polymeerirakenteita termoplastisesta sekä 
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polymeeri valosilloitettiin. 
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1 Introduction 
The history of load-bearing implants is long. However, the ancient orthopedic 
procedures generally resulted in amputation rather than repair. The first steps in the 
development of orthopedic implants were introduced in the late 19th century. One of 
the most important aspects was the development of antiseptic surgical techniques. 
Early hip arthoplasty and its development have been the foundation for implants in 
general. Numerous failures have provided the groundwork for better understanding 
of concepts such as biocompatibility, behavior of materials in body and functionality 
of the musculoskeletal system. [1] 
Life expectancy of the human being has risen considerably during the last century. 
The aging of the population increases the number of people suffering from 
degenerative diseases. Degenerative diseases effect on human joints and can lead 
to pain and loss in function. A significant proportion of population over the age 40 
suffers from these kinds of degenerative diseases. Musculoskeletal disorders are 
the most widespread human health problem. A normal self-healing process cannot 
repair effects of degenerative diseases. Therefore, there is a need for long lasting 
orthopedic implants, which restore the function or remove the pain. [2]  
The primary target of this thesis was to study the possibility to prepare three-
dimensional (3D) bioactive hybrid materials consisting of titanium mesh and 
biodegradable polymer. The planned application area is orthopedic implants. The 
role of titanium is to function as a load-bearing component, whereas the polymer 
matrix offers suitable porous structure for cell-ingrowth. The biodegradable polymer 
matrix includes bioactive glass to induce cell growth. Titanium alloy meshes were 
manufactured by electron beam melting (EBM). The big advantage of this method is 
the possibility to manufacture 3D components according to the model with high 
accuracy. During the work, the use of bone graft as a filler in titanium mesh was also 
investigated.  
This thesis consists of a literature part and an experimental part. The literature part 
includes an overview of the properties and structure of bone. Requirements for 
biomaterials in orthopedics are presented. The role of titanium as implant material is 
introduced and different methods to manufacture porous titanium are described. The 
target of this study was to prepare titanium/polymer hybrid materials. Therefore, 
recent methods used to prepare polymer/titanium hybrid materials are presented. 
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Since the EBM method was used in the experimental part, it is discussed more 
widely in the literature part. Finally, the literature part focuses on the anatomy of 
spine and spinal implants because it is the planned application area. 
In the experimental part, two different biodegradable polymers are used. The first is 
photo-crosslinkable polycaprolactone (PCL) and the second is thermoplastic 
polycaprolactone. Firstly, four-branched PCL oligomers were synthesized. 
Oligomers were methacrylated to receive a photo-crosslinkable oligomer. These 
oligomers were blended with bioactive glass and salt after which EBM manufactured 
titanium mesh was filled with mixture. The mixture was cross-linked, salt was 
leached to receive a porous structure and compression testing was performed. 
Secondly, thermoplastic PCL was used and other methods to prepare porous 
polymer structure were tested: freeze-extraction, freeze drying and dipping. Freeze-
extraction samples were characterized using scanning electron microscopy (SEM) 
and micro-computed tomography (μCT) visualizations.  
In addition to biodegradable polymers, also bone graft was used. Titanium mesh 
was filled with crushed bone graft and imaged with μCT and cone beam computed 
tomography (CBCT). Titanium mesh filled with bone as well as two samples of 
trabecular bone were compression tested. The obtained compression test results 
were compared with literature values for bone and EBM manufactured titanium 
mesh.   
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LITERATURE PART 
2 Properties and structure of bone 
Bone tissue makes up to 18 % of the weight of the human body. Bone tissue 
belongs to the group of connective tissues and has several important functions. 
First, it supports soft tissue and protects internal organs. Second, it provides an 
attachment for tendons of most skeletal muscles and assists in movement along 
with skeletal muscles. Third, it stores and releases minerals, especially calcium and 
phosphorus, maintaining critical mineral balances. Furthermore, red bone marrow in 
certain bones produces red blood cells, white blood cells and platelets. Finally, it 
also contains yellow bone marrow, which stores triglycerides and functions as a 
chemical energy reserve. [3] 
 
2.1 Structure of bone  
The skeletal system can be divided into trabecular bone and cortical bone by the 
structure. Trabecular bone has a sponge-like trabecular structure that occupies the 
inner region of the epiphysis and metaphysis whereas cortical bone is a semi-solid 
shell that covers the bone. [4]  Trabecular bone is also called cancellous or spongy 
bone. [5] Cortical bone has biomechanical, supportive and protective properties. [4] 
Figure 1 shows the anatomy of long bone. Long bones such as the femur or tibia 
have two epiphyses and one diaphysis. Epiphyses are made of trabecular bone 
covered by a shell of cortical bone. Diaphysis is composed primarily of cortical bone. 
[1] 
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Figure 1. Anatomy of a long bone. [1] 
Cortical bone is the main tissue type of the skeletal system. Up to 80 % of the entire 
adult skeletal mass consists of cortical bone and only 20 % consists of trabecular 
bone. The surface area of cortical bone is relatively small, 33 % of the total bone 
surface, and the surface to volume ratio is 2.5. [4] 
Cortical bone is porous. The porosity is due to Haversian canals, Volkmann’s canals 
and resorption cavities. The pores contain primarily nervous tissue and blood 
vessels. The Haversian canals are nearly parallel with the major axis of bone and 
are interconnected by Volkmann’s canals. The Volkmann’s canals are oriented 
perpendicular to the skeletal loading axis. The canals form a three-dimensional 
network throughout the cortical bone. Inside this network, there are circulatory 
vessels and nerves. The network functions also as extracellular fluid path allowing 
the exchange of nutrition, nerve signals, and metabolites between bone and other 
tissues. [4] The porosity of cortical bone that is due to the Haversian and 
Volkmann’s canals ranges from 5 - 30 % [1]. 
Osteons are cylindrical conformations and comprised of individual sheets of 
mineralized tissue (lamellae). A diameter of an osteon is 200-250 µm and thickness 
of a lamella is 1-5 µm. Each osteon contains approximately 20 - 30 lamellae that 
wrap around the Haversian canal. Lacunae are ellipsoidal, 5 - 8 µm long pores 
containing osteocytes. The lacunae are interconnected by channels called canaliculi 
(approximately 0.5 µm in diameter). The organization of cortical bone is illustrated in 
Figure 2. [1] 
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Figure 2. The organization of cortical bone into osteons. [1] 
Cortical bone is constantly renewing in response to environmental signals and 
microdamage. The complex process of renewal is called remodeling. During this 
process pre-existing osteons are partially removed to make space for newly 
generated osteons. [4] 
The surface area of trabecular bone is larger when compared to that of cortical 
bone. The surface to volume ratio is approximately 20. Trabecular bone is 
composed of a large number of a rod or plate shaped trabeculae (Figure 3). 
Trabeculae form a sponge-like network. [4] The network is open three-dimensional 
interconnected structure. [1] 
 
Figure 3. Illustration of the network structure of trabecular bone, showing both sheet-
like (plate) and thin and beam-like (rod) morphologies. [1] 
 
 
6 
 
A cellular structure of trabecular bone is significantly less stiff in comparison with 
that of cortical bone. It is more isotropic at its macrostructure level although it is 
heterogeneous at the microstructure level. The structure of trabecular bone can be 
dramatically different depending on the anatomical site investigated and the health, 
age and an activity level of the individual. The trabecular bone porosity can range 
from 30 % to 90 %. The highest porosities are associated with elderly vertebrae. 
Figure 4 illustrates the structure of trabecular bone. [1] 
 
 
Figure 4. Schematic of trabecular bone structure in (a) the proximal femur and (b) 
vertebral body. [1] 
The proportions of trabecular and cortical tissues vary significantly depending on 
bone. The proportion of cortical bone of total bone in an ulna can be 92 %, whereas 
it is 62 % in a typical vertebra. [4] 
 
2.2 Composition of bone  
Bone consists of an organic matrix (20-40 %), inorganic minerals (50-70 %), cellular 
elements (5-10 %), and lipids (3 %). The organic bone matrix is mostly collagen 
molecules that are bundled together to form collagen fibers. Collagen fibers are 
aligned parallel to each other to form a lamella sheet. Hydroxyapatite (HA) is the 
predominant molecule of a bone mineral and is deposited in the gap regions of 
collagen fibers. [4] HA (Ca10(PO4)6(OH)2) is formed when calcium phosphate 
(Ca3(PO4)2) combines with calcium hydroxide (Ca(OH)2) [3]. HA exists in the form of 
needle-, plate- or rod-shaped crystals and it provides the bone matrix with 
 
 
7 
 
mechanical rigidity and load-bearing capacity. HA contains a lot of impurities that 
are either incorporated into the crystal lattice or absorbed onto the crystal surface. 
These impurities are mineral salts such as calcium carbonate (CaCO3), and ions 
such as magnesium, fluoride, potassium, and sulfate [3]. Impurities influence the 
solubility of the crystal and for that reason the HA in bone is more soluble than 
geologic apatite. [4] 
The major cellular elements of bone include osteoclasts, osteoblasts, osteocytes, 
bone-lining cells, along with the precursors of these specialized cells, and cells of 
the marrow compartment and the immune regulatory system. [4] Osteogenic cells 
are unspecialized stem cells. They are derived from mesenchyme where almost all 
connective tissues are formed. [3] 
The osteoclasts are bone resorbing cells with a diameter ranging from 20 to over 
200 microns. Osteoclasts may live for up to seven weeks, but the nucleus lives up to 
10 days. At the end of their lifespan osteoclasts migrate into adjacent marrow space 
and undergo apoptosis. [4] Apoptosis is a programmed cell death, which is a normal 
type of cell death. During apoptosis, the cell ceases its functions and in the end 
phagocytes engulf and digest the cell. [3] The osteoblasts are bone-forming cells 
that synthesize and secrete collagen to form an unmineralized bone matrix. 
Typically, osteoblasts are 15-30 microns cuboidal-shaped cells and they are 
activated by specific mechanical and nonmechanical stimuli. Active osteoblasts are 
transformed to bone-lining cells, osteocytes, or they undergo apoptosis. [4]  
The bone-lining cells are also known as resting osteoblasts because they are 
derived from the surface of osteoblasts. The bone-lining cells are interconnected as 
a cellular sheet that covers the bone surfaces. They are flat and elongated, about 1 
micron thick and 12 microns by their diameter. They serve as a barrier to protect the 
bone surfaces from inappropriate resorption by osteoclasts, other inflammatory cells 
and ions. The bone-lining cells may have a role in maintaining a suitable 
microenvironment for the growth of bone crystals.  The bone-lining cell density 
decreases with age. [4]  
Osteocyte is the main bone cell type in mature bone. About 95 % of total bone cells 
are osteocytes. The cell size and organelles reduce as the osteocyte ages. The 
lifespan of an osteocyte depends on the rate of bone turnover because osteocytes 
are removed during bone formation. Most of the osteocytes eventually undergo 
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apoptosis. The rate of apoptosis and bone loss are increased for example by aging, 
unloading and loss of estrogen. Overall, the total bone mass decreases 1 % per 
year. [4] 
  
2.3 Mechanical properties of bone 
The architecture of bone is complex and the properties of bone tissue vary 
remarkably. Porosity, pore size, mineralization and mineral density, cell type and a 
cytokines gradient feature affect the properties of the bone tissue. [6] The density of 
wet bone is 1990 g/cm3 [7]. 
The hardness of bone depends on the crystallized inorganic salts whereas the 
bone’s flexibility depends on its collagen fibers. [3,8] Collagen fibers and other 
organic molecules act as reinforcing components providing tensile strength. If 
mineral salts are removed from bone, the bone becomes rubbery and flexible. [3] 
The behavior of bone is similar to that of relatively brittle polymer composite material 
[8]. 
The mechanical properties of bone depend on age. After maturation, the tensile 
strength and modulus of elasticity of femoral cortical bone decline by approximately 
2 % per decade. [6] The biological variability often dominates the results of 
mechanical testing. In addition to age, activity levels and health conditions also 
gender, the stages of bone modeling and remodeling, mechanical or drug 
interventions, and bone metabolic disorders etc. affect the mechanical properties. A 
degree of mineralization and hardness or stiffness of the bone matrix may vary 
according to a site and a region. Accordingly, the part or origin of the bone must be 
specified. Also the direction in which the specimen is tested is important because 
the bone is anisotropic and the mechanical properties are direction-dependent. [4] 
The strain rate affects the mechanical testing results. Higher strain rates generally 
produce a higher modulus of elasticity, a higher strength, and a greater strain to 
failure when compared to specimens tested at lower strain rate. [7] 
Bone properties are not based on linear elasticity and the typical force-deformation 
curve is divided into four regions: toe (preloading) region, linear elastic region, non-
linear elastic (plastic, micro-failure) region, and failure region (Figure 5). [4] 
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Figure 5. A typical stress-strain curve showing the nonlinearity, often seen in 
indentation test of trabecular bone. [4] 
 
The testing environment may also influence the mechanical behavior of bone. The 
temperature, humidity, moisture and dryness are affecting factors in the 
environment. The physiological temperature is 37 °C. Testing at the room 
temperature 23 °C increases the Young’s modulus of bone about 2-4 % when 
compared to testing at the physiological temperature. The moisture of the specimen 
should be kept constant with physiological saline. If the bone specimen dries, it will 
become more brittle and it’s Young’s modulus and strength will generally increase 
and its toughness will decrease. Therefore testing should be conducted in 0.9 % 
saline at a controlled temperature of 37 °C. [4] Also drying the bone and re-wetting it 
produces small differences in mechanical behavior [7].   
The values for mechanical properties differ depending on a source. The values have 
a great range due to different treatment of specimens, age and health of donors and 
differences in sites of bones. The compressive and tensile moduli are similar. Tests 
for femoral specimens have also shown that there is no significant difference 
between the moduli at the 95 % confidence level [7]. Young’s modulus of the human 
bone is typically 10 – 30 GPa    [9-11]. The values for mechanical properties of 
cortical and trabecular bone are summarized in Table 1.  
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Table 1. Mechanical properties of cortical bone and trabecular bone. 
Bone type 
Compressive 
strenght 
(MPa) 
Tensile 
Strenght 
(MPa) 
Compression: 
Modulus of 
elasticity (GPa) 
Tension: 
Modulus of 
elasticity (GPa) Source 
Cortical bone 100 - 230       [5] 
Cortical bone, 
longitudinally 
170 - 190 120 -130   17 [1] 
205 133 
  
[7] 
195 133 17.4 17.4 [9] 
193 133 17 17 [8] 
Cortical bone, 
transversely 
133 51   11.5 [1] 
33 51 11.5 11.5 [8] 
130 52 
  
[7] 
133 51 9.6 9.6 [9] 
Trabecular 
bone 
2 - 12 
7 - 22   0.2 - 1.9    
[5] 
[12] 
 
Table 2 shows mechanical properties for different bone tissues. Long bones (arm 
and leg bones) have rather similar mechanical properties whereas vertebrae have 
remarkably lower values.  
 
Table 2. Mechanical properties of bone tissues. [13] 
Tissue Direction of test Modulus of elasticity (GPa) 
Tensile strenght 
(MPa) 
Compressive 
strength (MPa) 
Leg bones     
Femur Longitudinal 17.2 121 167 
Tibia Longitudinal 18.1 140 159 
Fibula Longitudinal 18.6 146 123 
Arm bones     
Humerus  Longitudinal 17.2 130 132 
Radius  Longitudinal 18.6 149 114 
Ulna Longitudinal 18.0 148 117 
Vertebrae     
Cervical Longitudinal 0.23 3.1 10 
Lumbar Longitudinal 0.16 3.7 5 
Spongy bone Longitudinal 0.09 1.2 1.9 
Skull Tangential - 25 - 
  Radial - - 97 
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3 Three-dimensional biomaterials in orthopedics  
The definition of a biomaterial has undergone changes during the evolution of 
materials science. At first, in 1987, a biomaterial was defined as a non-viable 
material used in a medical device, but later the reference to non-viability was 
removed. In 1999, the preferred definition proposed, that a biomaterial was a 
material intended to interface with body and the scope of biomaterials was solely 
within the domain of health care. Also other opinions were presented: a biomaterial 
was defined as a solid material which occurs in and is made by living organism. In 
2009, Williams concluded that a biomaterial is a substance that has been 
engineered to take a form which is used to direct the course of any therapeutic or 
diagnostic procedure in medicine. The definition states that a biomaterial can be for 
example metallic or ceramic and it does not have to be of biological origin as long as 
it interacts in body in desired manner. [14] 
 
3.1 History of orthopedic biomaterials  
Only 60 years ago the concept of biomaterials was not used. There were no 
implantable devices, formalized regulatory approval processes and understanding of 
biocompatibility. However, crude biomaterials have been used throughout human 
history generally with poor or mixed results. [15] According to archaeological 
evidence orthopedic procedures were performed in several ancient civilizations, yet 
frequently surgical methods leaded to amputation rather than repair. [1]  
Prior to 1950 most implants had a low level of success because of a poor 
understanding about biocompatibility and sterilization. [15] Nor was the knowledge 
of the musculoskeletal system fully understood. Early hip arthroplasties provided 
groundwork for the current field of orthopedics, fixation methods, and medical 
devices. The evolution of total hip replacement includes advancements in 
processing of materials and improved understanding of physiological conditions. [1]  
The first hip replacement was performed in 1891 using a cemented ivory ball. The 
implant was not successful. Between 1920 and 1950, numerous attempts were 
made to develop hip and knee prostheses. Materials like glass, acrylic, Teflon, 
chrome-based alloys, stainless steel, and other metals and alloys were used. The 
implants have been failed due to poor durability and harmful wear products. The first 
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successful hip joint prosthesis was implanted 1961 and consisted of a ultra-high-
molecular-weight polyethylene (UHMWPE) cup with femoral stem and a ball head 
made of cobalt alloy. [15] Compared with older materials, UHMWPE provided 
resistance to corrosion, fatigue and wear. UHMWPE and cobalt alloys are still used 
in total hip arthroplasty and they have undergone extensive improvements in 
processing, structural development, and manufacturing over 50 years. The fixation 
between the proximal end of femoral stem and bone is now achieved with press fit 
methods, acrylic bone cement, or porous coatings. Stability of an implant can be 
improved by cables, screws and rods. More recent developments are porous 
titanium or cobalt-chromium coatings on the femoral stem to enhance bone 
integration and introduction of crosslinked forms of UHMWPE for improved wear 
resistance. [1]  
In 1952 it was observed that titanium integrates into the bone tightly. The 
phenomenon was named osseointegration. Nowadays titanium and its alloys are 
used in most dental implants and in many other orthopedic implants. [15] 
 
3.2 Requirements for orthopedic biomaterials and scaffolds  
In the first generation of implantable devices, between the years 1940 and 1980, the 
best performance was achieved with materials that were the least chemically 
reactive. Implantable materials were selected and developed in such way that failure 
could be avoided. Materials in these long-term implantable devices had to be e.g. 
non-toxic, non-immunogenic, non-thrombogenic, non-carcinogenic and non-irritant, 
in other words the materials had to be biologically safe. These requirements defined 
the concept of biocompatibility. Biocompatibility was also defined as the implant’s 
ability to exist in contact with the tissues of human body without causing an 
unacceptable degree of harm to the body.  [16] 
Nowadays there are also implantable devices which are not intended to remain 
within an individual for a long time. Some applications require that the material 
reacts with tissues or degrades over time rather than stays inert. The application site 
affects as well: the response to a material can vary depending on site. Therefore 
biocompatibility was redefined in 1987 by David F. Williams as follows: 
“Biocompatibility refers to the ability of a material to perform with an appropriate host 
response in a specific situation.”  [16]  
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Biocompatible materials can be divided into different categories: bioinert, resorbable 
and bioactive materials. [5] Thin connective tissue capsules are formed around 
bioinert (biotolerant) materials. The capsule does not adhere on the implant surface. 
Bioresorbable materials resorb in the body and autologous tissue replaces the 
material. Bioactivity is usually interconnected with bone tissue. Bone tissue is 
formed around the bioactive implant, which strongly integrates with surrounding 
tissue. [2]      
Accordingly, biocompatibility is the most important aspect with implantable devices. 
There are also other important factors that affect the success of the implant. These 
factors are for example related to the mechanical properties of material and the 
performance of material in the implant site. In respect to scaffold, the porosity and 
pore size, as well as the scaffold’s surface properties have to be considered. 
The bone scaffold should serve as a template for cell interactions and for the 
formation of a bone extracellular matrix. The scaffold should also provide a 
structural support for new bone tissue. If the scaffold is biodegradable, the rate of 
biodegradation should meet the rate of bone remodeling. [6]  
Biological environment is harsh for implantable devices. Implants are constantly in 
contact with extracellular tissue fluid with a salt content of about 0.9 % at pH 7.4 and 
temperature of 37±1°C. The electrolytes in body fluid are sodium, chloride, and 
bicarbonate, and small amounts of potassium, calcium, magnesium, phosphate, and 
sulphate. There are also amino acids, proteins, plasma, lymph etc. [13] Implantable 
devices have to stand up in such an environment. 
An ideal bone replacement scaffold is osteoconductive, osteoinductive, and 
osteogenic. Osteoconductive means that the scaffold favors ingrowth of a new bone 
tissue. [17] Osteoconductive materials bind to bone and stimulate bone growth 
along the surface of the material. [5] The osteoconductive material provides a 
surface for cells to attach, proliferate, and deposit bone matrix [18]. Osteoconduction 
is the primary purpose of the scaffold material [6]. In osteoconduction, the 
biomaterial acts as a scaffold for new bone that grows from neighboring living bone. 
A scaffold is osteoinductive when it induces the transformation of osteoprecursor 
cells from the host into bone matrix producing cells [18,19]. The scaffold can contain 
cytokines, such as bone morphogenetic proteins, that cause the osseoinduction. 
Osteogenesis occurs when the scaffold is seeded before implantation with cells that 
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will establish the new centers of bone formation. [6] Osteogenic material has the 
intrinsic capacity to stimulate bone healing [18]. 
The concept osseo- or osteointregration is described as a direct bone-to-biomaterial 
interface without fibrous tissue. Osseointegration is useful, because greater forces 
can be transferred along integrated bone interfaces. It also eliminates or minimizes 
interfacial movement or a slip. [15] Without osseointegration, fibrous tissue is formed 
between the bone and the implant. Therefore, an appropriate surface material is 
extremely important for implant success. The surface chemistry, surface roughness 
and surface topography are important issues regarding osseointergation. [2] 
The orthopedic scaffold should have proper mechanical properties to allow load-
bearing. [17] Mechanical properties should be similar to those of bone repair site [6]. 
Stress shielding occurs when a scaffold is much stronger than bone [8,20,21]. A 
high rigidity implant can induce bone atrophy due to the absence of mechanical 
stress. Lower rigidity may delay or minimize the bone atrophy due to the mechanical 
stress. [22]. This bone resorption around the implant can consequently lead to 
implant loosening. The resorption is due to the stress shielding effect that leads to 
death of the bone cells. The implant’s fracture due to inadequate strength or the 
mismatch in mechanical properties between the bone and implant is called 
biomechanical incompatibility. [2] 
 
3.2.1 Porosity  
Porosity and pore size are important factors in bone formation in vitro and in vivo. 
Porosity is defined as the percentage of empty space in solid. The pores are 
necessary for the bone tissue ingrowth and formation because they allow the 
migration and proliferation of osteoblasts and mesenchymal cells. The pores are 
also important for vascularization. [6] The pores have to be open and interconnected 
to allow the above-mentioned functions. [5,23,24] The apertures between the pores 
should have diameters over 100 µm. [5] The interconnectivity is also essential for 
the diffusion of nutrients. [23]  
Higher porosity enhances osteogenesis. Thus, highly porous implants are preferred 
for bone regeneration. Even though the increase in pore size and porosity enhances 
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the bone ingrowth, it results in decreased mechanical properties. This is a critical 
aspect in load-bearing implants. [6]   
Kuboki et al. [25] showed the importance of porosity in bone regeneration. They 
compared solid particles of HA with porous ones. Particles were mixed with bone 
morphogenetic protein 2 (BMP-2). Porosity was 70 % and a pore size 150 µm. 
Direct osteoneogenesis occurred only in the porous scaffolds and no new bone was 
formed on the solid particles. [25]  
Porosity can be classified on the basis of the pore size. Macroporosity has a pore 
size greater than 50 µm and microporosity less than 10 µ. [6] In the literature, there 
are several results for optimal pore size [5] but no consensus [24,26]. Most studies 
suggest that the optimal pore size for bone ingrowth is 200-600 μm [27]. The 
minimum pore size required to generate mineralized bone is generally considered to 
be about 100 µm. The minimum pore size for angiogenesis, the formation of new 
blood vessels, is also 100 µm [5]. Unmineralized bone tissue grows into smaller 
pores 75-100 µm, whereas only fibrous tissue penetrates into even smaller pores (< 
75 µm). However, scaffolds with smaller pore sizes have also shown bone ingrowth 
under non-load-bearing conditions. Studies have shown better osteogenesis for 
implants with larger (> 300 µm) pores, because they allow vascularization and high 
oxygenation although the type of bone ingrowth depends on the biomaterial and the 
geometry of pores. [6]. The optimal pore sizes can be compared with normal 
haversian systems that reach an approximate diameter of 100-200 µm [6]. 
Even though macroporosity is important to new bone formation, also microporosity 
and the surface topology are significant. The nanometer scaled surface roughness 
and nanometer-sized pores on the surface can increase the cell activity. [5] A 
porous surface improves the mechanical interlocking between the implant and the 
bone. The surface roughness also enhances the attachment, proliferation and 
differentiation of anchorage-dependent bone forming cells.  [6]  
The internal architectural design of scaffolds may have a control over the overall 
geometry of newly formed bone. Cylindrical HA implants with two architecture 
designs, orthogonal and radial channels, were studied in vivo. Although the percent 
of the bone ingrowth was not statistically different, the overall shape of the 
regenerated bone tissue was significantly different. The orthogonal architecture 
resulted in an interpenetrating matrix, whereas in the radial design the regenerated 
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bone formed an intact piece at the center of the implant. [28] Also the pore geometry 
may affect bone formation. Longer and curved pores have been observed to hinder 
the penetration of mesenchymal cells and capillaries, which resulted in bone 
formation only on the outer surface of the hydroxyapatite implant. On the contrary, 
particle system scaffolds resulted in bone regeneration deeper in the material. [6]  
 
3.2.2 Biocompatibility  
Bone grafts are used to replace faulty or damaged parts of the body [29] for 
example in replacement of bone after removal of a tumor, in revision surgery of 
failed hip prostheses and in fusion of vertebrae. The bone grafts are divided to 
autografts and allografts. The autograft is patient’s own bone and its use is 
preferred. However, this is not always possible due to an insufficient supply of bone 
available or a poor quality of bone. [5] The allograft is taken from one individual and 
implanted in another of the same species. The process is called transplantation. [29] 
In addition to autografts and allografts, synthetic materials are used to replace bone, 
especially when autografts and allografts are not available. To improve 
biocompatibility of the synthetic implant, bioactive materials can be used.  
By definition, a bioactive material is one that elicits a specific biological response at 
the interface of the material, which results in the formation of a bond between the 
tissue and the material. There are two classes of bioactive materials: 
osteoconductive and osteoproductive (also called osteoinductive). Osteoconductive 
materials conduct bone growth along the surface of material and osteoproductive 
materials stimulate the growth of new bone on the material away from the 
bone/implant interface. [5]  
Synthetic hydroxyapatite (HA) and tricalcium phosphate (β-TCP) ceramics are both 
calcium phosphate ceramics and similar to the bone mineral. They are 
osteoconductive, crystalline materials, whereas bioactive glasses are 
osteoproductive and amorphous. Tri-calcium phosphate and certain bioactive 
glasses are resorbable. HA resorbs also, but very slowly. The dissolution products 
of HA do not stimulate the genes in the osteogenic cells. Therefore HA is only 
osteoconductive and can act as a bone replacement material rather than a 
regenerative material [5]  
 
 
17 
 
HA (Ca10(PO4)6(OH)2) forms when β-TCP (Ca3(PO4)2) combines with calcium 
hydroxide (Ca(OH)2) [3]. The rate of dissolution depends on the calcium-phosphorus 
ratio. Compounds with Ca:P ratio lower than 1:1 are not suitable for biological 
implantation. This is because their solubility and speed of hydrolysis increase with 
the decreasing hydrolysis Ca:P ratio. Therefore, β-TCP with Ca:P ratio 1.5 is more 
rapidly resorbed that HA with Ca:P ratio 1.67. [15]  
Many bioactive silica glasses are based upon the formula called 45S5, which 
contains 45 w% SiO2 and 5:1 ratio of CaO to P2O5. Glasses with lower ratios do not 
bind to the bone. [15]  45S5 is also the first and well-studied composition of 
Bioglass™. The base components in most bioactive glasses are SiO2, Na2O, CaO, 
and P2O5. [30] Compositions of different bioactive glasses under the trademark 
Bioglass™ are presented in Table 3.   
 
Table 3. Composition (w%) of different Bioglass™ formulas. [30] 
Component 45S5 
Bioglass™ 
45S5.4F 
Bioglass™ 
52S4.6 
Bioglass™ 
55S4.3 
Bioglass™ 
SiO2 45 45 52 55 
P2O5 6 6 6 6 
CaO 24,5 14,7 21 19,5 
Na2O 24,5 24,5 21 19,5 
CaF2   9,8     
 
After the immersion in body fluid, a hydroxycarbonate apatite layer is formed on the 
bioactive glass surface. The apatite layer is similar to the apatite layer in bone. This 
is assumed to be the basis of the reactivity of the glass [5]. The bone can chemically 
bind to the formed bioactive layer [31]. Bioactive glasses form a bond to the bone 
much quicker than ceramics. Moreover, bioactive glasses can bond to soft tissue. [5]  
Usually, ceramics have a high compressive strength and Young’s modulus and a 
low toughness and therefore they are brittle materials. The composition, structure 
and Young’s modulus of HA resemble those of bone. Porous HA and β-TCP can be 
both colonized by bone tissue. [5]  
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3.3 Biodegradable polymers in orthopedics 
Biodegradable polymers can be divided into two major classes: natural and 
synthetic. The division is made by the origin of polymer, not by the structure. 
Therefore the polymers in these classes have properties that vary widely inside the 
class. In general, synthetic polymers can have more application areas because they 
can be tailored to give wider range of properties. On the other hand, some natural 
polymers have functional groups suitable for tissue engineering and they are less 
prone to produce toxic effects. However, the functional groups and possible 
contaminants present in natural polymer can also produce unwanted immunological 
effects.  [32] 
The properties of biodegradable polymers can be customized by using copolymers. 
In biomedical applications, requirements include suitable mechanical strength, 
degradation time, surface properties and physicochemical parameters. In addition, 
the presence of functional groups effect on the properties of polymer in body. In 
bone repair the mechanical properties are particularly important. [32] 
By definition, biodegradation is the chemical breakdown of materials by the action of 
living organisms. It leads to changes in their physical properties. [15] A 
biodegradable polymer is not always bioresorbable. Bioresorbable polymers are 
eliminated totally in the body with no residual side effects. [33] Therefore, a 
biodegradable polymer used in a medical device should be bioresorbable and it 
should degrade and/or be removed completely in body. The degradation should take 
place in a predictable manner and the degradation products should not cause any 
undesirable effects at the implantation site or on any other body organs or functions. 
[32]  
The polymer matrix degrades by a hydrolytic and/or enzymatic attack. The 
degradation processes can be divided into bulk and surface erosion. In a bulk 
erosion process a polymer loses mass uniformly throughout the matrix and the 
degradation rate depends on the volume of the polymer rather than its thickness. 
[32] The molecular weight reduces in the entire polymer matrix and monomers or 
oligomers diffuse out. [33] 
In a surface eroding process degradation starts from the surface and continuously 
moves to the core of the polymer matrix. The lifetime of the polymer device is 
dependent on the thickness and therefore the thicker the device is, the longer the 
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lifetime is. [32] Polymer backbone is cleaved only on the surface and monomers and 
oligomers diffuse into the surroundings. Therefore the molecular weight inside the 
polymer does not usually change. [33] 
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4 Titanium scaffolds 
The most commonly used metals in orthopedics are stainless steel, cobalt-chrome 
(Co-Cr) alloys and titanium (Ti) alloys. The preferred titanium alloy used for implants 
is TiAl6V4. Aluminum and vanadium stabilize the titanium phase and result in 
excellent mechanical strength. The elastic modulus of TiAl6V4 is lower compared 
with stainless steel and Co-Cr alloys, which can decrease the stress shielding of 
bone. [5] Titanium and its alloys exhibit the most suitable characteristics for 
biomedical applications due to their high biocompatibility, specific strength, and 
corrosion resistance [11].  
Titanium has been used in several orthopedic applications. These include hip stems, 
joints, and osteosynthesis material such as screws, plates and nails [34]. Titanium 
has been most commonly used material for over 40 years for fabrication implants for 
dental and orthopedic purposes. [26] It seems that titanium alloys are now going to 
be the first choice of material for majority of orthopedic applications. [2]  
 
4.1 Properties of titanium and its alloys 
Ti and its alloys have an excellent corrosion resistance in physiological medium [23]. 
This is due to the formation of a very stable TiO2 oxide phase on the metal surface 
[5]. The oxide layer forms spontaneously and the thickness of the layer is up to 7 nm 
[35]. Ti and its alloys are mainly used in implants that replace hard tissue, such as 
artificial hip joints and dental roots [11].  
Commercially pure (CP) titanium and its alloys have good mechanical properties. 
They have a high strength-weight ratio, low elasticity modulus and fatigue strength 
compared with other metals. [23] CP titanium and TiAl6V4 ELI (Ti64, Extra Low 
interstitial) are the most commonly used titanium materials for implant applications 
[2]. The ultimate tensile strength of Ti64 is 900 MPa and the modulus of elasticity is 
110 GPa. [5] Ti64 is claimed to have a strength about 100 % higher compared to 
pure titanium. Al and V ions might have some toxic effects. However, these might 
not be released during long-term use and only minor ion release has been reported 
from clinically used implants. [36] 
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The Young’s modulus for bulk titanium alloy is 40 GPa at its lowest. That is greater 
than Young’s modulus of cortical bone, which is approximately 10-30 GPa. The 
mechanical properties of titanium and the mechanical biocompatibility of an implant 
can be changed with increasing porosity. An effective way to reduce the Young’s 
moduli of titanium and its alloys is to increase the porosity.  [11] 
 
4.2 Preparation of porous titanium 
There are several different ways to manufacture porous titanium. The preparation 
method has effects on porosity, pore size, the interconnectivity of pores, and the 
mechanical behavior of the scaffold. Available manufacturing techniques are e.g. 
electron beam melting (EBM), laser additive manufacturing processes, powder 
manufacturing process, environmental-electro-discharge-sintering [37], freeze 
casting, and rapid prototyping [24]. Random pores are formed in freeze casting [24] 
and powder manufacturing processes [9], whereas laser additive manufacturing 
[34], rapid prototyping [38]  and electron beam melting [12] form a controlled 
architecture. 
 
4.2.1 Powder manufacturing process (with sintering) 
Porous scaffolds can be manufactured using titanium powder. Oh et al. fabricated 
porous titanium scaffolds by controlling sintering conditions and powder sizes. The 
powders were sintered in a vacuum at different temperatures. The resulting 
scaffolds were porous and the pores were interconnected. Figure 6 illustrates the 
surface of manufactured scaffolds. [9] 
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Figure 6.  SEM micrographs of porous Ti compacts sintered at (a) 1300 °C with 374 
μm powder and (b) 1100 °C with 65 μm powder. [9] 
 
The space-holder technique is a powder manufacturing process. It allows the 
manufacturing of titanium foams with designed porosity. The choice of space-holder 
effects on the porosity, the pore size and pore morphology [39]. The space-holder is 
removed after sintering. Most space-holders are completely evaporated at low 
temperatures or are removed by a dissolution process. However, the toxicity of the 
space-holder is of a great concern, because it is difficult to ensure that it is 
completely removed from the foam. [37] Typical space-holders are for example 
sodium chloride (NaCl) [37], ammonium hydrogen carbonate and carbamide [39].     
Müller et al. prepared porous titanium scaffolds by powder metallurgy according to 
the space-holder procedure. They used commercially pure (CP) titanium powder. 
After sintering step (1200 °C) the scaffolds were treated with ethanol and ultrasonic 
to get rid of possible air pockets. The porosity was 65-70 % and pore size was 100 – 
700 µm. The majority of pores were between 250 and 500 µm (Figure 7). [35]   
 
Figure 7. SEM micrograph  if CP titanium foam, with porosity of 65-70 % and pores 
with a diameter of 350 to 550 µm. [35]   
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4.2.2 Titanium foam 
Titanium foams can be made different ways. Titanium foam can be produced by 
mixing titanium powder with organic solid binder powder and a foaming agent. The 
powder mixture is heated and the organic binder melts and foam forms. The result is 
a solid foamed structure comprising titanium particles and the organic binder. The 
structure is heated to eliminate the organic binder and finally sintered the remaining 
three-dimensional network with interconnected porosity. [40] This type of titanium 
foams have been successfully tested as implants in the rabbit femurs and the tibias 
of rats. [41] 
Another way to manufacture titanium foam has been used. Titanium foam is made 
by impregnating a form made of open-cell polyurethane (PU) foam with solution 
consisting of titanium powder and binding medium. PU and binding agents are 
vaporized and the remaining titanium is sintered (Figure 8). [42]  
 
Figure 8. Titanium foam. [42] 
 
 
4.2.3 Laser additive manufacturing 
Laser additive manufacturing (AM) includes laser sintering (LS), laser melting (LM) 
and laser metal deposition (LMD). Different phrases are used depending on the 
institutions and companies. AM consolidates and shapes the feedstock (typically 
powder material) layer by layer and normally uses a computer controlled laser as 
the energy source.  [34] 
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LS is based on spreading powder layer by layer and subsequent laser sintering. LS 
system normally consists of a laser, an automatic powder layering apparatus, a 
computer system for process control and some accessorial mechanisms. Different 
types of lasers are used and they influence on the consolidation of powder because 
of the different wavelengths and energy densities of lasers. In LS process, the laser 
melts the powder only partially. Therefore powder characteristics and laser 
processing conditions have to be carefully determined. [34]  
LM has the same processing apparatus and procedures as LS. The only difference 
is that metallic powder melts completely in LM. In recent years, laser processing 
conditions have continuously improved. This leads to improved microstructural and 
mechanical properties. LM processed material shows a better densification rate, 
surface smoothness and microstructural homogeneity under optimal processing 
conditions compared with LS processed material. Nonferrous pure materials can be 
processed with LM, but LS process is not suitable for pure metals. However, LM 
requires high laser power, higher energy level, thin powder layers and longer 
building time. [34] 
In LS and LM the powder supply is pre spread, whereas in LMD powder is fed 
coaxially. In LMD the powder is fed in a gas delivery system. The laser beam and 
powder are focused on the same place and moved in the z direction to control the 
height of the scaffold. The workpiece is moved in the x-y direction by the computer 
controlled drive system under the beam/powder interaction zone, which forms the 
cross-sectional geometry. The geometry formed can be complex and have high 
dimensional accuracy. [34]   
 
4.2.4 Rapid prototyping 
Rapid prototyping (RP) combines computer-aided design (CAD) with computer-
aided manufacturing (CAM) and builds objects with predefined microstructure and 
macrostructure. Traditionally, RP has concentrated on polymeric and ceramic 
materials. RP can also be used to manufacture porous Ti scaffolds. [38] 
Li et al. used TiAl6V4 powder to prepare porous scaffolds. First, TiAl6V4 powder was 
mixed with an aqueous solution of methylcellulose and stearic acid to obtain slurry. 
Second, the scaffold was formed by RP and the samples were dried. Finally, 
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scaffolds were sintered in a high vacuum furnace. A fully interconnected porous 
network with highly controllable porosity and pore sizes was formed (Figure 9). [38] 
 
Figure 9. Environmental scanning electron microscope (ESEM) micrograph of 
TiAl6V4 scaffold. Optimal concentration (66 vol% TiAl6V4 powder used). [38] 
 
 
4.2.5 Electron beam melting  
Electron beam melting (EBM) can also be considered as one branch of AM. The first 
step in EBM is to create a three-dimensional model with CAD. The geometrical data 
of the component is sliced into layers with constant thickness, because the 
component is generated layer by layer. A fully interconnected porous network and 
highly controllable porosity and pore size can be manufactured with EBM. [43] The 
thickness of one layer is 100 µm [44], [45]. Components can be built up to size of 
150 mm x 150 mm x 180 mm [45].  The production of EBM components is 
performed under a vacuum atmosphere (10-4-10-5 mbar). This is especially important 
for titanium due to its high affinity to atmospheric gases like oxygen and nitrogen. 
[12] 
EBM machine reads the data from a CAD model and melts the first 100 µm metallic 
powder layer. [44] The process platform is lowered by the thickness of one layer and 
the process is repeated until the component is built. The process takes place in a 
powder bed. The metal powder which is not molten during the process supports the 
forming component. [12] The schematic picture of EBM process is presented in 
Figure 10.   
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Figure 10. Schematic picture of Arcam EBM system [43]. 
 
The component is cooled down either under a vacuum or helium atmosphere. The 
supporting powder is removed by powder blasting with the same powder as used in 
the building process. Therefore, the remaining powder can be reused after sieving in 
a new process. [12] Figure 11 shows a network manufactured by FIT Fruth 
Innovative Technologies Ltd and used in the experimental part of this thesis. 
 
 
Figure 11. Picture of cylindrical network manufactured by FIT Fruth Innovative 
Technologies Ltd.  
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Heinl et al [12] studied EBM manufactured titanium alloy (TiAl6V4, Ti64) networks 
with different process settings and pore sizes (Figure 12). They concluded that the 
mechanical properties of porous EBM manufactured titanium alloy depend on the 
relative density, pore architecture (open or closed pores) and anisotropy. Increasing 
the relative density raises the elastic modulus. The lowest relative density was 
achieved with the highest porosity of 87 %, largest pore size (strut length) of 1.8 mm 
and strut thickness of 0.4 mm. The process settings affect on the thickness of the 
struts in the network. For the material with the lowest density (0.13 g/cm3), the 
compressive strength at break was 16.3 MPa and elastic modulus 0.4 GPa. The 
porosities of structures were between 60 % and 87 % and the relative densities 
were between 0.13-0.40 g/cm3. Pore diameters varied between 0.67 and 1.82 mm.  
With the highest relative density the compressive strength at break was 118.8 MPa 
and elastic modulus 6.5 GPa. [12] Therefore, the mechanical properties can be 
adjusted by altering the process settings and pore sizes in EBM manufactured 
networks. 
  
Figure 12. EBM manufactured titanium alloy networks. [12] 
 
Cheng et al. [21] studied the compression deformation behavior of EMB 
manufactured Ti64 meshes with different porosities and strut sizes. With 86 % 
porosity, 3 mm strut length, 1 mm strut thickness and 0.62 g/cm3 relative density, 
the compression stress at break was 12.4 MPa and the compressive modulus was 
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0.54 GPa. As the relative density was increased to 0.73 g/cm3, the compression 
stress at break was 20.9 MPa and the compressive modulus was 0.89 GPa. 
However, they received also higher value for compression stress at break (113 
MPa) when the relative density was even higher (1.68 g/cm3) [21] 
Hrabe et al. [20] performed fatigue testing for EBM manufactured titanium alloy 
(TiAl6V4) networks. They observed a reduced fatigue lifetime compared to the 
expected value and proposed three possible reasons for that. First, μCT images 
revealed closed porosity within the struts, which may yield stress concentrations. 
Second, sintered particles and texture lines on the surfaces of struts may also yield 
stress concentrations. Third, the microstructure of EBM manufactured TiAl6V4 
(acicular α or martensite) is not optimal for high-cycle fatigue resistance. [20] 
Ponander et al. [46] cultured human osteoblasts in vitro on the surface of EBM 
manufactured TiAl6V4 scaffolds. The scaffolds had different surface roughness. After 
few days of incubation, osteogenic proliferation and differentiation genes were 
expressed. The cells were able to attach, proliferate and differentiate on TiAl6V4 
specimens with different surface types. [46] 
Palmquist et al. studied EBM manufactured TiAl6V4 meshes. They performed 
experimental studies in sheep. The study demonstrated osseointegration and high 
bone-implant contact throughout the porous scaffold. The porous implants showed 
also good long-term soft tissue biocompatibility and expressed thinner fibrous 
encapsulation compared to solid implants. [36] 
Applications for EBM manufactured Ti64 meshes has already been proposed. Li et 
al. designed acetabular cup with porous structure, cranial implant (Figure 13) and 
local porous structure for joint prosthesis. [47] Murr et al. proposed also acetabular 
cup design. Other fabricated orthopedic implant prototypes were a total knee implant 
and a tibial (knee) stem (Figure 14). [48] Li et al. proposed an EBM manufactured 
implant to repair a mandibular bone defect [27]. 
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Figure 13. EBM manufactured acetabular cup and cranial implant [47], modified.  
 
 
            
Figure 14. Total knee implant and tibial stem [48]. 
 
FDA has approved a product from Limacorporate S.p.a., which includes EBM 
manufactured Ti64. The Delta TT Acetabular System is a hip joint prosthesis. The 
Delta TT cup is manufactured using an EBM (Figure 15). [49] 
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Figure 15. The Delta TT cup [50]  
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5 Porous titanium/polymer hybrid materials  
There are different objectives to manufacture titanium/polymer hybrid materials, 
such as improving biocompatibility and mechanical properties. The application area 
for titanium/polymer hybrid materials is in orthopedics. 
Porous titanium has a good biocompatibility. However, it can be improved by filling 
the titanium pores with a polymer that exhibits biofunctionalities. [51] The elastic 
modulus of solid titanium is much higher than the one of cortical bone. The elastic 
modulus can be lowered by manufacturing porous materials. On the other hand, 
increasing porosity impairs also the mechanical strength of a titanium scaffold. The 
mechanical strength decreases due to the structural defects and the stress 
concentration around the pores. Therefore, a polymer filling can also be used to 
improve the mechanical properties. [52]  
Porous titanium used in titanium/polymer hybrid materials can be manufactured in 
different ways. The most common is the powder manufacturing process which is 
presented in the following review of literature. Used polymers are non-biodegradable 
high-density-polyethylene (HDPE), polyurethane (PU) [52] and 
polymethylmetacrylate (PMMA) [53], and biodegradable poly-L-lactide (PLLA) 
[51,54,55]. The polymer matrix can be non-porous or porous depending on the 
desired properties. 
 
5.1 Hybrid materials with non-biodegradable polymer 
The objective for manufacturing porous titanium/non-biodegradable polymer hybrid 
materials is to produce a material with mechanical properties comparable to those of 
human bone.  Nakai et al. [10] manufactured titanium scaffolds with different pore 
sizes and porosities. The pore sizes and porosities depended on titanium powder 
particle sizes, sintering temperatures, and manufacturing pressures. Titanium 
scaffolds were filled with PMMA. The PMMA filling increased the tensile strength of 
porous titanium with highly porous scaffolds. The effect of the PMMA filling on the 
Young’s modulus was not remarkable because the Young’s modulus of PMMA is 
considerably lower than that of porous titanium. PMMA filling may affect negatively 
on osteoconductivity of titanium. Figure 16 shows SEM picture of porous titanium 
and porous titanium/PMMA hybrid material with 45 % porosity.  [10] 
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Figure 16. SEM micrographs. A. Porous titanium. B. Porous titanium/PMMA hybrid 
material. [10]    
 
Wang et al. [52] used HDPE and PU to fabricate porous titanium/polymer hybrid 
materials. The porosity and pore sizes were controlled by varying the sintering 
process parameters. The pores were open and interconnected when porosity was 
over 25 %. The polymers were impregnated into the scaffold with the assistance of 
hydraulic pressure. Normal impregnating processes are capable of filling mainly 
over 125 µm pores. However, with hydraulic assisted system high viscosity 
polymers, such as HDPE and PU, can be impregnated into porous titanium with a 
pore size as small as 10 µm. Figure 17 shows titanium powder, porous titanium and 
titanium/polymer hybrid materials used in the study. [52] 
 
Figure 17. SEM micrographs. A. Titanium powder. B. Porous titanium, porosity 35 
%. C. Titanium porosity 37 %, Titanium/HDPE porosity 0%.   D. Titanium porosity 37 
%, Titanium/PU porosity 0%. [52]   
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5.2 Hybrid materials with biodegradable polymers 
Nakai et al. [51] studied hybrid materials further and replaced PMMA with PLLA. 
Porous titanium was fabricated through the powder manufacturing process. L-lactide 
was polymerized to PLLA inside the porous titanium in a nitrogen atmosphere under 
a vacuum at 160 ºC for 1h. PLLA did not have a remarkable effect on Young’s 
modulus or tensile strength. However, PLLA increased the compressive strength 
with highly porous titanium scaffolds. Figure 18 shows SEM micrographs of titanium 
with 45 % porosity filled with PLLA. [51] 
 
 
Figure 18. SEM micrographs. A. surface of porous titanium filled with PLLA. B 
Cross-section of porous titanium filled with PLLA. [51] 
 
 
PLLA filling in the pores degrades during immersion in Hank’s balanced salt solution 
(HBSS). HBSS is a stimulated body fluid which includes organic components (Na+, 
K+, CA2+, Mg2+, HCO3-, Cl-, HPO42- , and SO42-) [56], but no cells or biological 
polymers. The energy dispersive X-ray spectroscopy (EDX) results indicate calcium 
phosphate formation after eight weeks immersion. After twelve weeks immersion X-
ray diffraction (XDR) profile proved the formation on hydroxyapatite. [51] 
The PLLA degradation rate increases with a prolonged immersion time. However, 
after eight weeks immersion the weight loss rate of the material becomes low. This 
may have two reasons: formation of HA on the surface of material increases weight 
and/or decreases the degradation rate of PLLA. The decrease of the degradation 
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rate is due to smaller the contact area with HBSS by covering of the surface of the 
material.  [51]  
Watanabe et al. [54] also used porous titanium and PLLA to fabricate hybrid 
materials. Porous titanium was fabricated through mixing titanium powder and NaCl 
and sintering the titanium matrix. Porous titanium was obtained by dissolving the 
NaCl in water. PLLA was melted and introduced into the pores of titanium samples 
under vacuum. PLLA did not fill the pores thoroughly and the amount of bubbles 
varied from place to place. PLLA reinforced the titanium matrix but there was a 
mechanical gradient. Figure 19 shows porous titanium with 50 % porosity filled with 
PLLA. [54]  
 
 
Figure 19. Optical microscope image of titanium/PLLA hybrid material. [54] 
 
 
5.3 Hybrid materials with porous biodegradable polymer 
Hybrid materials with a porous polymer matrix are not studied extensively. Vrana et 
al. [55] used porous titanium manufactured by fusing spherical titanium microbeads 
(Figure 20A). In other words, they used the powder manufacturing process. The 
biodegradable polymer used was PLLA. Porous polymer was manufactured using 
the freeze extraction method, which is easy to scale up. Freeze extraction is a 
thermally induced phase separation technique. The method forms open, 
interconnected pores via extraction of the frozen solvent from frozen polymer 
solution via a non-solvent for the polymer. The solvent can be for example dioxane 
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and non-solvent ethanol. The pores were formed with a Teflon mold that directs the 
process and permits a formation of pore gradients. The mold directs the movement 
of the extraction fluid. The morphology of polymer pores was similar with and 
without titanium and the titanium scaffold was totally engulfed by the polymer 
network (Figure 20B). [55] 
 
 
Figure 20. A. SEM image of porous titanium. B. ESEM image of porous 
titanium/porous PLLA hybrid material. [55] 
 
 
 
 
 
  
 
 
36 
 
6 Spinal implants 
Scoliosis and related back pain, loss of motion, and spinal fracture are reasons for 
the need of spinal implants. Disc arthrosis and collapse also require medical 
treatment. One of the most common causes of back pain is degenerative disc 
disease (DDD) of the intervertebral discs which results in a loss of disc height and 
mechanical function. [1] Conservative treatments for back pain are bed rest, anti-
inflammatory medications, and physical therapy. If these are ineffectual, spinal 
implants are recommended. [57] The number of surgical procedures in the treatment 
of symptomatic DDD is increasing. However, the effectiveness of surgery has not 
had only convincing evidence. [58] 
 
6.1 Anatomy of the spine 
The function of the spinal column is to protect the spinal cord and to be a connection 
to the central nervous system. The spinal column comprises 33 individual bones 
called vertebrae that are divided into three groups: cervical, thoracic and lumbar 
vertebrae (Figure 21). The sacrum comprises 4-5 fused bones and the tailbone 
(coccyx) contains 3-5 fused bones. The cervical region (C1-C7) enables the rotation 
of the neck and the movement of the head. The thoracic vertebrae (T1-T12) house 
the rib case and assists the motion of bending, twisting, and side extension. Lumbar 
spine (L1-L5) provides support of the body weight in sitting or standing. The sacrum 
functions as the foundation of the pelvis. The sacrum and the coccyx together 
support and balance upright body. [1] 
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Figure 21. The anatomy of a healthy spine. [1] 
 
The vertebrae are separated by intervertebral discs that absorb shocks (Figure 22). 
The outer layer of disc is called the annulus, which protects the soft viscoelastic 
interior, the nucleus. The nucleus has several functions: bearing the axial loads of 
the spine, providing a pivot point for torsional movement of the lower body and 
attaching the vertebrae together. [1] The healthy disc allows also bending, flexion 
and torsion of the spine. Altogether the discs make up about one third of the spinal 
length.[59] 
 
 
Figure 22. Intervertebral disc between vertebrae. [1] 
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6.2 Challenges with spinal implants 
As with any medical device, the spinal implants have to be biocompatible, offer 
resistance to wear and fatigue damage, and withstand loading. There are six 
degrees of freedom in the kinematics of spine, including flexion-extension, lateral 
flexion, and axial rotation. Therefore, in addition to compressive and tensile axial 
strength, the implant must offer also flexural strength and torsional strength. Also, 
the position in the spine affects greatly on the loads and strains. These factors also 
make the design of implants extraordinarily challenging. The complex biomechanics 
of the spine is illustrated in Figure 23.  [1]  
 
Figure 23. Biomechanics of the spine. [1] 
 
In comparison to general orthopedics, the spinal implant’s situation in the spine is 
more difficult when dealing with infection. A spinal infection is difficult to treat and an 
infection in the presence of an implant is even more difficult. This is due to the 
anatomical position of the implant as well as the difficulty and risks of revision 
approaches [60]. Therefore, infections should be prevented instead of treating them. 
Methods to prevent infections are including antibiotic prophylaxis (preventive 
medication), surgical technique to avoid necrotic tissue, reduction of haematomas, 
optimizing surgical conditions and treating co-existing infections. There is a 
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consensus that patients should receive antibiotics before the spine surgery. [61] In 
addition, some patient groups make spinal implantation challenging, such as 
smokers, patients with multiple past surgeries, and patients with poor bone quality 
[62].  
 
6.3 Present state of spinal implants  
There are two types of medical devices used in the spine. The first type of device 
are those that lead to fusion of two or more vertebra [63]. Spinal fixation (spinal 
fusion) is a method where the fractured spine is stabilized with screws and plates or 
rods. Also wire and bone grafts have been used to spinal fixation. Contemporary 
spinal fixation is made with screws and rods [64]. Spinal fusion is the ”gold standard” 
for treatment of degenerated intervertebral discs [59]. It is also the most popular 
surgical operation in spine [57]. In spinal fusion, the degenerated intervertebral disc 
is removed and the vertebral bodies are fused [59]. The removal of intervertebral 
disc is called discectomy [57]. 
The second type is a disc replacement where a damaged or diseased disc is 
removed and replaced with an implant.  [1] Unlike spinal fusion methods, artificial 
total disc replacement (TDR) is designed to restore the segmental motion of the 
spine or to give back some of the motional freedom. Currently used implants have 
only medium outcome success and have relatively high re-operation rates. [59] It is 
still uncertain if TDR is more effective and safer than fusion [65]. 
 
6.3.1 Disc replacement implants 
There are several disc replacement implants. Lumbar spine implants are different 
compared to implants in cervical spine due to different biomechanical requirements. 
This literature review focuses on recent lumbar intervertebral implants.  
The ChariteTM has been a widely used lumbar intervertebral implant. The core is 
ultra-high molecular weight polyethylene (UHMWPE) and the endplates are made of 
cobalt-chrome (Co-Cr) alloy (Figure 24). UHMWPE acts as mobile unit allowing the 
normal motion of the spine. [1] The ChariteTM disc has been taken off the market 
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because of the poor sales, even though it had a lifetime of over a quarter of a 
century [66]. 
 
 
Figure 24. The ChariteTM lumbar intervertebral implant. [67] 
 
The Pro-DiscTM consists also of CoCr alloy and UHMWPE. The implant utilizes 
metal-on-plastic bearing coupling. [1] Figure 25 shows the assembled Pro-DiscTM 
that consists of three components. The problem with both metal-on-plastic implants 
is polymer wear, subsidence and migration, even though both ChariteTM and Pro-
DiscTM are successful implants. [1] The Pro-DiscTM is the only commercially available 
disc prosthesis in the United States, because ChariteTM is not available anymore 
[66].  
 
  
Figure 25. The Pro-DiscTM intervertebral implant. [68] 
 
 
 
41 
 
MaverickTM implant is made of CoCr alloy and it is a metal-on-metal implant. The 
implant has a fixed posterior center of rotation, which mimics the kinematics of the 
intervertebral motion. [1] Figure 26 shows the MaverickTM implant. The MaverickTM 
total disc replacement implant has been used in Europe and Australia, but is not yet 
FDA (U.S. Food and Drug Administration) approved in United States. Metal-on-
metal surface might cause metal wear which results in a significant host reaction 
[66]. 
 
Figure 26 The MaverickTM implant. [69] 
 
The FlexicoreTM implant is also made of CoCr. A ball-and-socket joint links the 
superior and inferior endplates. The endplates are dome shaped and there is a 
rotational stop and a tension bearing. These features prevent the separation or 
dislocation of the endplates. [1] Flexicore’s preliminary trial results did not show 
clinical relevant differences between TDR surgery and fusion techniques. Even 
though the authors reported decreased pain intensity and a slightly better functional 
impairment in Flexicore group than in the fusion group, the statistical significance 
was not reported. [58] The FlexicoreTM implant is shown in Figure 27.     
 
 
Figure 27. The FlexicoreTM implant. [68]   
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In addition to MaverickTM, ChartieTM, Pro-DiscTM and FlexicoreTM, there are also other 
lumbar TDRs under investigation and emerging to market, such as Mobidisc, XL 
TDR, Freedom lumbar disc, Activ-L, Kineflex and Triumph. [63] Figure 28 shows the 
designs of the lumbar disc replacement TDRs not yet in market.  
 
 
Figure 28. Lumbar TDRs. (a) Kineflex; (b) Mobidisc; (c) XL TDR; (d) Freedom; (e) 
Activ-L; and (h) Triumph. Modified [63] 
 
 
6.3.2 Cages 
Interbody cages and vertebral body replacements enable the bone healing across a 
previously mobile motion segment. Some cages are intended to contain bone graft 
or an osteogenic substance. [63] Autograft is the “gold standard” for spinal fusion. 
Anterior lumbar interbody fusion (ALIF) has become one of the primary choices for 
eliminating motion between vertebrae. [62] Also other surgical techniques are used, 
such as transforaminal lumbar interbody fusion (TLIF) and posterior lumbar 
interbody fusion (PLIF). 
Interbody cages are used between two vertebrae. Their purpose is to restore lost 
disc height and relieve back pain. There are numerous interbody cage models and 
retailers.  
Titan Spine offers a titanium Endoskeleton® interbody fusion devices. They have 
devices for different surgical techniques. [70] Trabecular Metal™ Material from 
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Zimmer is made of tantalum. It is highly porous, structural biomaterial, which 
promises rapid, substantial bone ingrowth [71]. DePuy Syntes has several interbody 
cage products such as Polyetheretherketone (PEEK) vertebral spacer and titanium 
alloy (Ti-6Al-7Nb) SynCage Spacer [72]. Spine Craft offers ORIO-AL ALIF PEEK-
Optima® Cage [73]. ALIF PEEK cage from BM Korea Co. is made also from PEEK-
OPTIMA™ material [74]. Figure 29 shows pictures of presented implants.  
 
Figure 29. Interbody cages. (a) Endoskeleton® [70]; (b) Trabecular Metal™ Material 
ALIF Device [71]; (c) PEEK vertebral spacer [72]; (d) SynCage Spacer curved [72]; 
(e) ORIO-AL ALIF PEEK-Optima® Cage [73]; (f) ALIF PEEK cage [74]. 
 
The MOSS titanium mesh cage (“Harms mesh cage”) and SynexTM cage are 
vertebral body replacement devices (Figure 30). MOSS has been used successfully 
for 25 years. It was developed in 1986 and the technology is relatively simple. 
Cylindrical shape titanium mesh has reinforcement rings at each end. This is a 
stable structure which is filled with bone graft before implantation. The primary filler 
is autograft.  There are different sizes of MOSS cages. [62] Syntex is newer 
vertebral body replacement device. Its height is adjustable and it is extended in situ 
to the required size. [75] 
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Figure 30. (a) MOSS vertebral body replacement. [76]. (b) Titanium Mesh Cage 
packed with autogenous trabecular bone resected from the fracture site, [77] 
modified. (c) SynexTM [76] 
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EXPERIMENTAL PART 
7 Scope of the research 
The target of this thesis was to investigate preparation of 3D bioactive 
titanium/polymer hybrid materials. The primary target was the preparation of hybrid 
material combining titanium mesh and porous biodegradable polymer matrix. In 
addition, filling titanium mesh with crushed bone graft was investigated.  
The planned application area for titanium/polymer hybrid materials is orthopedic 
implants. The goal was to manufacture materials that have proper mechanical 
properties for load-bearing applications. The materials should also have a suitable 
porous structure for cell ingrowth and be bioactive to induce osteogenesis. The role 
of titanium is to function as a load-bearing component, whereas the polymer matrix 
offers a suitable porous structure for cell-ingrowth and a matrix for bioactive glass 
(BAG) to induce osteogenesis. 
In this study different methods to prepare titanium/polymer hybrid materials were 
studied. The used biodegradable polymer was PCL because it is one of the 
polymers that are FDA approved. Therefore it can enter to clinical stage remarkably 
faster compared to a new polymer without FDA approval. Both photo-crosslinkable 
and thermoplastic PCL were used. Cross-linkable PCL oligomers were synthetized 
from ε-caprolactone and methacrylated whereas thermoplastic PCL was used as 
received.  
Porous PCL was prepared by salt leaching method from photo-crosslinkable 
methacrylated oligomers. Salt leaching was used because it is easily performed 
method and with the used salt calcium chloride hexahydrate (CaCl2 · 6 H2O) the 
pores formed have a suitable pore size and they are interconnected [78]. However, 
with salt leaching there is always a possibility that part of the salt remains in the 
polymer matrix especially with larger samples. Therefore, other methods to prepare 
porous samples were used with thermoplastic PCL. These are freeze extraction, 
freeze drying and dipping. There is no concern with unwanted chemicals in the 
complete sample, because the solvents used in these methods evaporate.   
Scanning electron microscope (SEM) and micro computed tomography (μCT) were 
used to analyze the pore size and porosity of freeze extraction samples. μCT was 
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used also with titanium mesh samples filled with crushed bone to determine the 
consistence of filling. 
The load-bearing capacity of the prepared samples is an important aspect when 
considering the application area in orthopedics. Therefore, compression testing was 
performed for the samples containing titanium or bone, as well as PCL and 
PCL+BAG samples prepared by crosslinking. 
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8 Materials 
The polymer used in this research was polycaprolactone (PCL). Both photo-
crosslinkable polycaprolactone oligomer and thermoplastic polycaprolactone were 
used.  Thermoplastic polycaprolactone was provided by Purac Biomaterials. PCL 
was dissolved into 1,4-Dioxane (Sigma-Aldrich Chemie, Germany) for the freeze 
extraction and coating process. For the freeze drying process, chloroform (Merck 
Chemicals, Germany) was used. 
Star-shaped polycaprolactone oligomers were synthetized from ε-caprolactone (CL, 
Sigma-Aldrich Chemie, USA) using stannous(II)2-ethylhexanoate (Sn(Oct)2) as an 
initiator (Sigma-Aldrich Chemie, Germany) and pentaerythritol (PERYT, Sigma-
Aldrich Chemie, Germany) as a co-initiator. Methacrylic anhydride (MAAH, Sigma-
Aldrich Chemie, Germany) was used for the functionalization. Camphorquinone 
(CQ, Sigma-Aldrich Chemie, Germany) was used as the photo-initiator for the 
photopolymerization of functionalized polycaprolactone oligomers. All chemicals 
were used as received.  
Bioactive glass (S53P4, Vivoxid LTd, Finland) was used as a bioactive component 
in polymer matrixes. S53P4 is a mixture of CaO, Na2O, P2O5, and SiO2. The particle 
size used in this study was ≤ 40 mm. For making porous polymer structures by salt 
leaching, calcium chloride hexahydrate (CaCl2 · 6 H2O, Sigma-Aldrich Chemie, 
Croatia) was sieved to obtain appropriate size crystals. Chloroform-d (Euriso-top, 
France) was used for nuclear magnetic resonance (NMR) measurements. 
The titanium alloy networks were ordered from a German company FIT Fruth 
Innovative Technologien GmbH. The networks were made by EBM process. The 
alloy powder used was TiAl6V4 extra low interstitial (Ti64 ELI) which is highly 
resistant to corrosion and biomedically compatible. The manufacturer promises 
titanium structure to be 100 % dense. [45] 
Eero Huotilainen from Business, Innovation, Technology (BIT) research unit of the 
Department of Industrial Engineering and Management, Aalto University School of 
Science designed the structure of titanium networks. Networks for cages were 
designed according to the dimensions given by Professor Petri Lehenkari from 
University of Oulu. The networks are presented in Figure 31 and Figure 32. The 
dimensions for mesh were following: width 40 mm, depth 30 mm, front height 15 mm 
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and back height 8 mm. The angle between front and back is 12 º. Dimensions of 
struts were selected to have a thickness of 1 mm and length of 4 mm. Pretests have 
shown that these dimensions allow the network to be filled with polymer. The 
structure was chosen to be diamond cubic crystal structure. The networks for 
compression tests were selected to be cylinders (Figure 33) with height 15 mm and 
diameter 14 mm. The general structure of the networks is similar for both meshes.    
  
Figure 31. Design of cage implant. Images received from BIT.  
 
 
Figure 32. Design of cage implant from side. Image received from BIT, modified. 
 
      
Figure 33. Design of cylinder network. Images received from BIT. 
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The porosity of cylindrical networks was determined by comparing the weight of the 
porous implant with the theoretical weight of solid sample with the same dimension 
and density. The density of solid TiAl6V4 is 4.43 g/cm3. [36] The volume of cylindrical 
networks was 3.02 cm3. The weight of a solid sample should thus be 13.38 g. The 
average weight of cylindrical mesh was 0.79 g. The weight of cylindrical mesh was 
6 % of the weight of solid cylindrical piece. Therefore, the porosity of meshes was 
approximately 94 % and the bulk density was 0.26 g/cm3.   
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9 Methods 
Four different methods were used to manufacture porous polymer matrices from 
cross-linkable PCL oligomers and thermoplastic PCL. To prepare cylinder shaped 
samples for compression testing, Teflon molds were used. The diameter for a mold 
was 17 mm and height 20 mm. A top side and a bottom side of the mold are open. 
The same molds were used also for samples with thermoplastic PCL. In addition to 
PCL samples, titanium mesh was filled with crushed bone graft. 
 
9.1 Preparation of cross-linked polycaprolactone samples 
The polycaprolactone oligomers were synthesized using bulk ring-opening 
polymerization described earlier [79]. The polycaprolactone oligomers were 
polymerized in a batch reactor at 160 ºC under a nitrogen atmosphere. The ε-
caprolactone monomer was fed into the reactor with appropriate amount of PERYT 
for 1 h to dissolve the co-initiator into the monomer. The initiator Sn(Oct)2 (0,02 mol-
%) was added and the polymerization was continued for 5 h.  
The co-initiator affects the structure of the polymer and increases the reaction rate 
of polymerization. PERYT is a symmetrical star-shaped molecule which has 4 
functional OH-groups in equivalent positions. Therefore it yields 4-arm polymers. 
The amount of PERYT affects the molar mass of oligomer. [79] As oligomers with 
low viscosity were preferred, high amounts of PERYT were needed. For the chosen 
amount of PERYT, 12 mol-% in respect of the monomer amount, theoretical molar 
mass is 1087 g/mol. The chemical reaction of the preparation of oligomers is 
presented in Figure 34. 
 
Figure 34. The reaction scheme of ring-opening oligomerization of ε-caprolactone. 
Modified [80]. 
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After the synthetization, the hydroxyl end groups were methacrylated with MAAH. 
The functionalization was carried out in a batch reactor at 60 ºC for 24 h. The 
chemical reaction of functionalizing oligomers with methacrylic anhydride is 
presented in Figure 35. 
 
 
Figure 35. The reaction scheme of functionalization with methacrylic anhydride. 
Modified [80]. 
 
Functionalized polymers were isolated by the precipitation of the reaction mixture in 
n-hexane. The precipitation was made 10 consecutive times. Hexane was mixed 
with magnetic stirrer in room temperature with reaction mixture and precipitation was 
carried out in ice bath. Finally, methacrylated oligomers were dried in vacuum.  
For crosslinking, 1 w-% CQ was added to methacrylated oligomer and stirred with 
spatula. The mixture was left under an aluminum cup for 1h. Aluminum prevents 
light access to the mixture and avoids light induced crosslinking. The procedure 
dissolves CQ more efficiently and a more homogenous mixture is received. The next 
step was to add bioactive glass (20 w-% of polymer) and/or CaCl2 · 6 H2O (67.6 w-
% of PCL-BAG composite). Finally, the mixture was poured into Teflon molds which 
were placed on silicone coated polyethylene terephthalate (PET) films (Votafilm® 
2645, Isovolta AG, Austria) and metal plates to ease the transferring of molds. In 
case of titanium mesh, the mold was first filled halfway with polymer mixture. 
Second, mesh was filled with polymer paste. Thirdly, titanium mesh was pushed to 
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the mixture. Finally, mold was filled full. Filled molds were allowed to rest under 
aluminum cups for minimum 1 h to remove air bubbles from the polymer mixture.   
Filled molds were covered with silicone coated PET film and placed into the Triad® 
2000 light curing system (DENTSPLY, Canada). First, both sides were cured two 
times for two minutes and after that the films were removed. Second, both sides 
were cured for six minutes and samples were removed from the mold. Finally, both 
sides of samples were cured six minutes three consecutive times. In total, both 
sides were cured for 28 minutes. 
When CaCl2 · 6 H2O was used, the remaining salt had to be removed with ethanol. 
The skin of the samples was removed with sharp blade. A beaker was filled with 
ethanol and a magnetic stirrer was placed on the bottom. A rack was placed into 
ethanol so that the magnetic stirrer could rotate freely. Samples were placed to the 
rack allowing the whirling ethanol to rinse the CaCl2 · 6 H2O out of the samples for 
four days. After salt was removed, the samples were dried in vacuum for one day. 
Abbreviations for the samples are presented in Table 4 and picture of samples is in 
Figure 36. 
 
Table 4. Abbreviations for photo-crosslinked PCL samples. 
Abbreviation bioactive glass titanium mesh porous 
PCL 
   p-PCL 
  
x 
PCL-BAG x 
  p-PCL-BAG-titanium x x x 
 
 
 
Figure 36. Samples for compression testing. From right: PCL, PCL-BAG, p-PCL and 
p-PCL-BAG-titanium. 
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Weights of samples were measured before curing and when the samples were 
finished. Also the removed polymer skin was weighted. It was assumed, that 
polymer skin contains only PCL and BAG. CaCl2 · 6 H2O could not be removed 
totally from the polymer matrix. Approximately 83 w-% of CaCl2 · 6 H2O was 
dissolved. Therefore, the porosity of the samples was approximately 49.4 vol % 
instead of the theoretical 59.5 vol %. The effect of titanium meshes to the porosity is 
not approximated. 
 
9.2 Preparation of thermoplastic polycaprolactone samples 
Freeze extraction, freeze drying and dipping methods were also tried to manufacture 
porous polymer samples and polymer coated titanium meshes. Thermoplastic PCL 
was used in these methods.  
 
9.2.1 Freeze extraction  
Freeze extraction is a method to manufacture porous polymer structures. It has 
been used for example in manufacturing porous membranes of PLLA/PCL solutions 
[81,82] and of titanium/ biodegradable polymer (PLLA) scaffolds with microporous 
polymer structure [55]. Freeze extraction is a thermally induced phase separation 
technique. The pores are formed via extraction of the frozen solvent from frozen 
polymer solution via non-solvent for the polymer. The technique has several 
advantages: it does not have residual solvent problem, is easy to scale up, and 
forms open, interconnected pores. Molds can be used to direct the process to form 
pore gradients to control cell migration. [55] On the other hand the pores are small; 
5-10 µm [82].  
PCL (0.26 g) was dissolved into 1,4-dioxane (5 g) with a magnetic stirrer. This 
should yield approximately 95 % porosity. When bioactive glass (0.04 g) was used, 
it was added immediately before freezing the samples. The Teflon mold was 
attached to a plastic petri dish with freezing distilled water in freezer at -22 ºC. 
Polymer solution was poured into the mold and silicone coated PET film was placed 
on the mold. For the samples prepared for SEM, in the case of bioactive glass and 
polymer solution, the mold was freeze also with liquid nitrogen before pouring the 
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solution. This is because µCT images revealed bioactive glass to be sunk to the 
bottom of the sample. Therefore, faster freezing should be used to avoid high 
concentrations of bioactive glass on the bottom.  
After 2 hours in the freezer, the samples were detached from the petri dish. The 
samples were placed in beakers filled with – 10 ºC ethanol. The beakers were 
placed on a rack in thermostat (RM 6 B, Lauda, Germany). The thermostat was filled 
with deionized water – monoethylene glycol mixture (HD Zero BS6580, The Aspo 
Company, Finland) with ratio 1:1 and the temperature of the mixture was adjusted to 
be -10 ºC. The samples were immersed in ethanol for 2 d 19 h.  
After the immersion in ethanol, the samples were removed and placed in a fume 
hood to allow ethanol to evaporate for 1 d. Finally, the samples were dried in 
vacuum overnight. The abbreviations for the samples are following: the PCL sample 
is PCL and the PCL sample with bioactive glass is PCL-BAG.    
The scaffolds obtained by the described method were highly porous and soft. They 
had a hole in the middle on the top of the sample. They do not have suitable 
mechanical properties for load-bearing applications. Therefore the scaffold made 
with this technique needs a load-bearing matrix, such as titanium mesh.            
Lebourg et al. [81] and Gaona et al. [82] prepared solutions of mixes of PCL and 
PCL/PLLA blends in different weight ratios. All polymer-dioxane solutions were 
frozen in liquid nitrogen. Freezing the solutions with liquid nitrogen was also tried. 
However, that did not freeze the sample fast enough and part of the solution drained 
out of the mold. This yielded un-uniform samples.  
Vrana et al. [55] dissolved PLLA in dioxane-water binary mixture and froze the 
samples at -80 ºC. Dioxane-water binary mixture was tried in this study. There was 
no possibility to freeze samples in -80 ºC. Therefore, the samples were frozen with 
liquid nitrogen or in freezer at -22 ºC. Liquid nitrogen yielded to bursting of the 
solution out of the mold. In the freezer, big holes emerged during freezing. 
Therefore, freezing samples with liquid nitrogen and using dioxane-water mixture 
was not considered a success. However, if compared to freezing at -22 ºC faster 
freezing at lower temperature might be affordable in preventing holes in the 
samples.   
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9.2.2 Freeze Drying 
Freeze drying can be used to manufacture porous polymer structures. It is also 
based on phase separation technique, in which phase separation of homogenous 
biodegradable polymer solution occurs due to a lowered temperature. Using 
temperature which freezes the solution, the phase separation mechanism is solid-
liquid demixing. That forms frozen solvent and concentrated polymer phases. The 
frozen solvent is removed and pores are formed into spaces that were originally 
occupied by the solvent. The morphology of prepared porous structure is adjusted 
by polymer concentration, solvent and cooling rate. These factors affect to the 
mechanism of phase separation and thus pore structure formation. [83]  
2 g PCL was dissolved into 10 ml chloroform in room temperature. The Teflon mold 
was attached to a plastic petri dish with freezing distilled water in freezer at -22 ºC. 
PCL solution was poured into the mold and liquid nitrogen was poured outside the 
mold. The solution started to freeze from the borders of the mold and small hole 
appeared on the center of the sample.  
The frozen sample was placed in a freeze dryer (Zree Zone -105 ºC 4.5 Liter 
Cascade Benchtop Freeze Dry system, Labconco, USA) and dried in vacuum for 4 h 
30 min. Polymer was erupted from the center of the sample (Figure 37). 
 
 
Figure 37. Sample prepared by freeze drying.  
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9.2.3 Dipping 
PCL was dissolved in chloroform to obtain a solution with suitable viscosity for 
dipping. To dissolve PCL, a magnetic stirrer was used. A suitable viscosity was 
received when 5 g PCL was dissolved in 30 ml chloroform.  
The titanium mesh was dipped in polymer solution. The solution formed membranes 
between edges. These membranes were broken with gaseous nitrogen flow. The 
dipping was made three consecutive times to achieve uniform coating. After every 
dipping, the solvent was allowed to evaporate for minimum 20 minutes before new 
dipping. 
The dipping was also tested with 20 w-% of bioactive glass. Bioactive glass was 
added to polymer solution and mixed with magnetic stirrer. The bioactive glass 
blended well with the solution, but sunk after a while to the bottom of the beaker. 
Therefore, the solution had to be stirred before every dipping. A suitable number of 
dipping in this case was three to four times.   
 
9.3 Preparation of titanium-bone graft samples 
Titanium-bone graft samples were prepared at University of Oulu at the Department 
of Anatomy and Cell Biology. The bone graft is bone received from a patient. The 
blood and bone marrow are removed from the bone graft. The bone graft had been 
crushed and stored at 80 % ethanol in refrigerator.  
The titanium mesh was cleaned with Digital ultrasonic cleaner (SS-802, ProsKit, 
USA). The ultrasonic cleaner was filled with distilled water and titanium meshes 
were cleaned in the ultrasonic cleaner for 7 min and 50 s.  
The titanium networks were filled up with crushed bone. Tweezers and pestle were 
used as tools in filling. The filling of titanium mesh with crushed bone took quite a 
long time, because the bone was hard to get inside the mesh. Smaller bone pieces 
would have been easier to be used in filling. Figure 38 shows the filling process.    
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Figure 38. Filling of titanium mesh. Right: Mesh could be filled from other side only 
to half way. Left: Tweezers and pestle was used in filling.  
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10 Results and discussion 
10.1 Characterization of cross-linkable polycaprolactone samples 
The structure of polymers was determined using a Bruker Ultrashield 400 Hz NMR 
spectrometer (Billerica, MA, USA). The samples (5-10 mg) for 1H measurements 
were dissolved in 0.5 ml d-chloroform (99.8 % deuteration). The measurements 
were performed at 25 ºC. 
PCL oligomers were polymerized in bulk using SnOct2 as the initiator and PERYT as 
the co-initiator to produce star-shaped low molecular weight oligomers. The 
monomer conversion was complete as no monomer peak (2.66 ppm) was observed 
in 1H-NMR spectrographs. The methacrylation was complete as OH end groups 
(peaks 3.65 ppm and 3.50 ppm) were not observed. Figures 39 and 40 show the the 
1H-NMR spectras of PCL oligomers before and after methacrylation, respectively. 
 
 
Figure 39. 1H-NMR of OH-terminated PCL oligomer. 
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Figure 40. 1H-NMR of methacrylated PCL oligomer. 
 
 
10.2 Size-exclusion chromatography 
Waters (Milford, MA, USA) size-exclusion chromatography (SEC) was used to 
analyze the number average molecular weight (Mn) and polydispersity indexes 
(PDIs) of different PCL samples. The Waters SEC system consists of a Waters 
717plus autosampler, a Waters 510 HPLC pump and a Waters 2414 refractive index 
detector and columns involved in molecular weight separation. Chloroform was used 
as eluent. The results were processed with the Empower software by Waters using 
narrow molecular weight polystyrene calibration. The samples (10 mg) were 
dissolved in chloroform (10 ml) before the analysis.  
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Table 5. shows results for relative molar masses and PDIs for samples. Three 
batches of methacrylated PCL oligomers were prepared. These are denoted as PCL 
I, PCL II and PCL III.   
Table 5. Relative molar masses of thermoplastic PCL and different metharylated 
oligomer samples. 
Sample Mn (g/mol) PDI 
Thermoplastic PCL 69600 1.8 
Methacrylated PCL oligomers 
  
 
PCL I 2800 1.2 
 
PCL II 3000 1.1 
  PCL III 3100 1.2 
 
 
10.3 Determination of gel content 
The gel content is the insoluble fraction which is produced by crosslinking. The gel 
content can be determined by extracting polymer with solvents. The determination of 
gel content was made for photo-crosslinked PCL samples. The samples have been 
in compression testing. The cross-linked PCL was taken from the middle of the 
compression specimen to determine the crosslinking in the middle of the samples. 
Before testing, the samples had been kept in vacuum for two days to remove 
moisture.   
Specimens were prepared by cutting a rectangle piece of 120-mesh stainless steel 
cloth. The mesh was folded to form a square. Two sides of this square are closed by 
folding the cloth at the edges to obtain a pouch open at the top. The pouch is 
weighted. Approximately 0.1 mg of the PCL is weighted and placed in the weighted 
pouch. The open side of pouch is folded over to form a cage. The total weight of 
PCL and the pouch is calculated. Three samples were prepared. 
A Soxhlet extractor was used in the determination. A round-bottom flask (500 ml) 
was filled with 350 ml acetone. Acetone was heated to boiling point and the samples 
were placed in the thimble. The samples were extracted for 20 hours in acetone. 
After extraction, the samples were placed in vacuum for 13 h. Cage and PCL were 
weighted and gel content was calculated. The average gel content for the samples 
was 99.88 %.  
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10.4 Compression testing 
Compression testing was performed using Instron 4204 (Instron, USA) apparatus. 
The software used was Bluehill 2 (Instron, USA). Six kinds of specimens were 
prepared: solid PCL, porous PCL, solid PCL-BAG composite, porous PCL-BAG-
titanium mesh hybrid material, titanium mesh and titanium mesh filled with bone 
graft. The amount of samples was three for all sample groups. All the PCL samples 
were prepared by photo-crosslinking of methacrylated PCL oligomers. The shape of 
the tested specimens was cylindrical. The specimens were prepared using the same 
Teflon mold with diameter 17 mm and height 20 mm. However, the sizes of the 
finished specimens varied slightly. Firstly, this is due to the fact that the titanium 
meshes had to be a bit smaller compared to the mold so that they could fit in. 
Secondly, porous PCL samples (p-PCL and p-PCL-BAG-titanium) prepared by 
crosslinking methacrylated PCL oligomers had a polymer skin on the surface. The 
skin had to be removed before dissolving the CaCl2 · 6 H2O in order to promote the 
salt leaching process.  
The testing was done at 23 ºC and 50 % humidity. The testing speed was 1 
mm/min. 5 kN load was used to porous samples and samples with titanium meshes. 
5 kN load was not enough for solid PCL and PCL-BAG samples. Therefore, 50 kN 
load was used for these samples. The compressive modulus and compressive 
stress and strain at yield were calculated. The means and standard deviations were 
calculated from the results.  
Figure 41 and Figure 42 show the compression stress-strain curves for samples 
containing titanium mesh. The samples have similar compressive stress values 
regardless of bone or polymer matrix filling. The curves in Figure 41 have similar 
shape. The titanium-bone sample has some crushed bone on the top and the 
bottom of the sample. The curve shows first how crushed bone moves and 
compresses before close contact between the titanium and compression plates. 
There was only one titanium-bone sample. Therefore no further conclusions about 
the effect of the bone graft on compressive stress can be made.  Figure 41 shows 
also how titanium mesh starts to break one strut at a time after the compression 
stress at break. The breaking pattern was similar for all the titanium mesh samples.   
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Figure 41. Compression stress-strain curves for titanium meshes and titanium-bone 
sample. 
 
Figure 42 shows the curves for p-PCL-BAG-titanium samples. The p-PCL-BAG-
titanium samples have different curve shape in the beginning of testing compared to 
titanium mesh samples. It is due to the polymer that is first compressed. As the 
testing is continued, the titanium mesh begins to affect the result.   
 
Figure 42. Compression stress-strain curves for p-PCL-BAG-titanium samples.  
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Figure 43 shows compression stresses at break for samples containing titanium. 
The 95-% confidence borders are determined for titanium and p-PCL-BAG-titanium 
samples. For the titanium-bone sample, confidence borders are not determined 
because only one sample was tested.  
 
Figure 43. Compression stresses at break with 95-% confidence borders. 
 
Figure 44 shows the compression stress-strain curves for porous PCL samples (p-
PCL). Compression stress at break is significantly lower compared to all the other 
compression samples. Therefore, the porous PCL matrix in titanium mesh does not 
effect on the compression stress at break. This fact can be also seen comparing 
Figure 41 and Figure 42. The values show also that porous PCL could not be used 
without reinforcing titanium in any load-bearing application. 
 
Figure 44. Compression stress-strain curves for p-PCL samples. 
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The non-porous PCL and PCL-BAG samples have the highest compression 
stresses at break (Figure 45 and Figure 46). The breaking of the samples starts at 
one side by cleavage of a piece, and continues by a small piece at a time.   
 
Figure 45. Compression stress-strain curves for PCL samples. 
 
 
 
Figure 46. Compression stress-strain curves for PCL-BAG samples. 
 
Trabecular bone samples had been stored at 80 % ethanol in refrigerator. Before 
testing the samples were in the testing environment for 1 h. There were two 
samples: the first one was from the femoral head and the second one from the 
femoral neck. The femoral neck sample was a lot more porous from other end. The 
difference in porosity can be seen in compressive strength at break in Figure 47.  
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Figure 47. Compression stress-strain curves for trabecular bone samples. Bone 1: 
Femoral head. Bone 2: Femoral neck. 
 
The modulus of elasticity is also important factor in mechanical behavior. The stress 
shielding occurs when a scaffold is much stronger than bone [8]. Therefore, it is an 
advantage that the value of modulus of elasticity of the material is close to that of 
bone. The literature values for trabecular bone are 0.02-1.9 GPa. [12] Figure 48 
shows compressive modulus values for all samples. The confidence borders for 
bone samples have not been calculated because there was only one specimen of 
each sample containing bone. As seen in Figure 48, the compressive modulus 
values for titanium meshes are close to those of trabecular bone. The sample p-
PCL-BAG-titanium is exception. This is due to the porous polymer around the 
titanium mesh. 
 
Figure 48. Compressive modulus with 95-% confidence borders for all the 
compressive samples. 
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The formability of Ti64 mesh after EBM manufacturing has been a subject of 
interest. Therefore, a set of experiments was made.  As the titanium mesh starts to 
break after 9.5 % strain, it is interesting to see if the deformation reversible with 
lower strain. The titanium meshes were compressed so that the strain was 2 %, 4 
%, 6 %, 8 % and 10 %. 2 % strain corresponds 0.3 mm strain. The sample height 
was measured before and immediately after the compression test. The height was 
also measured 12 hours after compression test to determine whether the 
deformation was reversible or irreversible. 
The measurements showed that deformation was reversible with 2 and 4 % strains. 
6 % strain yielded small, under 0.04 mm deformation. 8 % strain (1.2 mm) yielded 
deformation of 0.3 mm and 10 % 0.6 mm. When the strain was 10 %, the first 
breakage of titanium strut had happened. This affects already to the compression 
strength of titanium mesh. Therefore, the possible deformation is very small. To 
conclude, Ti64 mesh should not be deformed because the possible deformation is 
small and there is a great risk of breaking the struts.    
 
   
10.5 Scanning electron microscope images 
The scanning electron microscope (SEM) images were taken at Aalto University 
Nano-talo with Sigma VP (Zeiss, Germany). Emitech K100X (Quorum Technologies 
Ltd., United Kingdom) was used to coat samples with Gold/Palladium sputtering. 
The coating was performed with 30 mA coating current for 2 min. The titanium mesh 
does not require sputtering. The imaged samples were EBM manufactured titanium 
mesh, bioactive glass powder and two freeze extraction manufactured samples 
(PCL and PCL+BAG).   
Figure 49 shows the surface of titanium mesh. EBM uses titanium powder and 
supposedly these powder particles are still seen on the surface of the mesh. The 
particle size is approximately 9 µm. The rough surface of EBM manufactured 
titanium mesh may be benefit for adhesion of osteogenic cells [47]. 
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Figure 49. SEM images of EBM manufactured titanium mesh. 
 
Figure 50 shows SEM images of bioactive glass (BAG) powder. This BAG was used 
also in the freeze extraction sample and PCL samples prepared from photo-
crosslinkable oligomers. As shown in the images, the particle size of the BAG 
powder was not uniform, but rather distributed. 
 
Figure 50. SEM images of bioactive glass (S53P4). 
 
Figure 51 and Figure 52 show vertical and horizontal cross-sections of PCL and 
PCL-BAG samples prepared by freeze extraction. The Teflon mold has directed the 
evaporation of 1,4-dioxane and alignment of pores has been formed. The pores are 
≥ 30 μm. There is no remarkable difference between the two samples. Furthermore, 
similar particles as seen in Figure 50 of bioactive glass cannot be seen in Figure 52.  
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Figure 51. SEM image of PCL sample prepared by freeze extraction. Vertical (left) 
and horizontal (right) cross-section.  
 
 
Figure 52. SEM image of PCL-BAG sample prepared by freeze extraction. Vertical 
(left) and horizontal (right) cross-section. 
 
 
10.6 Micro-computed tomography  
Micro-computed tomography (µCT) imaging was carried out at University of Oulu 
with SkyScan1176 high resolution in-vivo x-ray microtomograph. The SkyScan 1176 
is used at preclinical research. The imaging shows that bone fills the mesh quite 
evenly. Figure 53 shows section of titanium mesh filled with crushed bone. During 
filling, few titanium particles have been pulled away from the mesh as can be seen 
in the Figure 53. Analysis of data reveals bone and tissue volumes in the sample. 
The percent of bone volume is 22 % and the percent of titanium volume is 7 %. 
Therefore, the total volume of titanium and bone is 29 % and the void space is 71 %. 
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The amount of void space can be reduced by using crushed bone graft with smaller 
particle size.  
 
Figure 53. µCT image of titanium-bone sample. Titanium is purple and bone green. 
 
Figures 54 and 55 show µCT images of PCL and PCL-BAG samples prepared by 
freeze extraction, respectively. µCT images reveal large voids that can be clearly 
seen in the middle of the samples. The presentage of total porosity volume was 
66 % with PCL sample. The closed porosity was under 0.05 %. Therefore, most of 
the pores were interconnected. The pore alignment is clearer in PCL sample 
compared to PCL-BAG sample. 
 
Figure 54. µCT images of PCL sample prepared by freeze-extraction. PCL is yellow 
and voids are purple. 
Figure 55 reveals that bioactive glass has sunk to the bottom of the sample. This is 
probably due to a too slow freezing of the sample which gives BAG time to sink. The 
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volume percent of PCL was 18 % and BAG 8 %. Therefore, the porosity was 74 %. 
The volume percent of BAG of polymer matrix was 34 %.  
 
Figure 55. µCT images of PCL-BAG sample prepared by freeze-extraction. PCL is 
yellow, bioactive glass is white and voids are purple. 
 
10.7 Cone beam computed tomography 
Cone beam computed tomography (CBCT) imaging was carried out at University of 
Oulu with Planmed Verity® Extremity CT Scanner (Planmed Oy, Finland). The 
Planmed Verity® is developed for orthopedic imaging of patients and it provides high 
resolution 3D images. CBCT images were taken of titanium alloys mesh filled with 
crushed bone (Figure 56).  
 
 
Figure 56. CBCT images of titanium-bone sample. Titanium mesh is colored red. 
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CBCT allows the studying different components of sample. One component can be 
faded out and other component can be viewed. Figure 57 shows a titanium/bone 
graft sample in which the bone graft is faded out. 
 
 
Figure 57. CBBT image of circular titanium mesh at different angles.   
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11 Conclusions 
The target of this thesis was to manufacture 3D porous bioactive load-bearing hybrid 
material. The primary material choice was to combine titanium mesh with a 
biodegradable polymer. Bioactivity was obtained by using bioactive glass or bone 
graft. However, in this thesis the bioactivity was not tested with a cell cultivation 
experiment. On the other hand, bioactive glass is widely known to induce 
osteogenesis. Secondly, also the use of crushed bone graft as a titanium mesh filler 
was investigated. Bone graft is a naturally bioactive material which has already been 
used in several cage applications 
The pore size in orthopedic implants should be 200-600 μm to allow bone ingrowth 
[27]. The favorable porosity of biomaterials is 60-70 % [78]. The pore size of EBM 
manufactured Ti64 mesh was 4 mm and porosity was 94 % because the mesh was 
planned to be filled with biodegradable polymer with a suitable porosity. The porosity 
of the freeze extraction sample was 66 % and the porous structure was 
interconnected as the μCT imaging showed. However, the pores were probably too 
small (≤ 30 μm) for osteoblasts as seen in SEM images. Therefore, the freeze 
extraction method should be improved concerning the pore size if there is a wish to 
use it in preparing a scaffold material. The μCT images also revealed that the BAG 
sunk to the bottom of the sample. Therefore, fast freezing is remarkably important 
for the even distribution of BAG in polymer matrix.  
Porosity of photocrosslinkable polymers (56 %) was obtained by the salt leaching 
method. All of the salt was not possible to be removed from polymer matrix which 
was noticed by weighting the samples. Salt leaching with CaCl2 · 6 H2O is not 
probably suitable method for samples of this size. Another possibility might be that 
the sieving CaCl2 · 6 H2O with 0.5 mm sieve used in this study does not yield 
optimal salt particle size for the method. Salt leaching with CaCl2 · 6 H2O has been 
reported to yield pore size 220 ± 80 μm [78]. The gel content inside the cross-linked 
PCL samples was high. This proves that in case of clear samples, good 
photocrosslinking is possible to obtain with larger samples. However, the shading 
effect of bioactive glass or titanium mesh to photocrosslinking is not known.  
EBM manufactured titanium meshes had compressive stress at break approximately 
8 MPa at 9.5 % strain and compressive modulus 0.17 GPa. These values are close 
to the values of trabecular bone, of which compression stress is 2-22 MPa and 
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elastic modulus 0.02-1.19 GPa depending on the source. Also the trabecular bone 
samples measured had a similar compressive stress at break (4 and 16 MPa) and 
compressive modules (0.21 and 0.44 GPa). Therefore, titanium mesh might be 
suitable for load-bearing applications in replacing trabecular bone. In addition, at 
least one implant consisting EBM manufactured Ti64 alloy has got FDA approval. 
There are also several CE-certified and FDA-cleared implants on the market 
produced according to the EBM manufacturer Arcam AB [84]. To conclude, EBM 
manufactured titanium mesh is an attractive option as a bone implant material. 
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12 Suggestion for future work 
First of all, the design of an implant should be considered carefully. The overall 
structure of titanium mesh needs evaluation. The roughness of titanium surface can 
be seen as an advantage but also as a demerit. The surface roughness gives a tight 
fit with vertebrae. On the other hand, the rough surface makes it more difficult to get 
the implant between the vertebrae, especially when the space between the 
vertebrae is very small. Screws to assist the fixation of the implant might be needed 
to avoid slip. Therefore, designing places for screws would be an option for further 
development. Now the focus has been on preparing interbody cages. One option 
could also be to prepare longer vertebral body replacements. Those are needed in 
situations, where one or more vertebrae have to be removed, such as in cancer.  
As cited earlier, it is profitable that spinal implant patients receive antibiotics in 
connection with surgery [61]. Therefore, when a biodegradable polymer is used, 
antibiotics could be added in polymer matrix. This would create a drug release 
device. There is also an option to grow bone cells into the scaffold before 
implantation, which creates an osteogenic implant.   
Mechanical properties of hybrid materials need revising. Titanium mesh has now 
had a compression strength at break similar to trabecular bone values in literature. 
However, as spine has a complex mechanical environment, other mechanical 
testing would be profitable, such as shear and bending testing. Fatigue testing has 
shown that EBM manufactured Ti64 mesh is not optimal for applications with cyclic 
load. [20] Therefore, the Ti64 mesh might not be the optimal material in spine. 
Relative density has effect on compressive strength of EBM meshes [12]. Therefore, 
through increasing the relative density, it would be possible to prepare titanium 
networks with a higher compressive strength. This would allow the use of titanium 
mesh scaffolds in cortical bone. On the other hand, the application area could also 
be in environment where load-bearing property is not essential, such as fundus 
implant.   
Bioactivity has now been proposed to yield from bioactive glass in biodegradable 
polymer matrix or crushed bone graft. The path should now be decided; the choice 
will affect the design of titanium mesh. With bone graft the design should help 
maintaining the bone graft inside the titanium mesh. If the use of biodegradable 
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polymer would be the choice, the porosity should be optimized. Salt leaching might 
not be the best solution due to the remaining salt in the matrix. As freeze extraction 
produces too small pores and freeze drying did not succeed, some method to 
prepare porous polymer matrix inside the titanium mesh should be found.  
The porous structure of freeze extraction and drying methods is formed during the 
freezing state. Therefore, suggestions to improve freeze extraction and freeze 
drying methods are partly similar. For example, water has been noticed to effect on 
porous structure of PLLA dissolved in dioxane/water binary mixture [83].  
The gel content with photocrosslinkable PCL samples was high. The gel content of 
samples with titanium or BAG was not determined because it is difficult with titanium 
samples and the test method is not valid with fillers. Therefore, to make sure that the 
crosslinking is high, there is a possibility to use a dual initiator, which initiates the 
crosslinking due both light and temperature.  
Also the resorption rate of polymer in the body should be investigated, because one 
of the aims in biodegradable implants is to match the resorption rate with the cell 
growth rate. In addition to PCL, other biodegradable polymers should be considered 
because polymers have different resorption rates. It is also possible to adjust the 
resorption rate by using copolymers.  
When there is a decision about implant materials, the next step in the research 
would be cell cultivation test. The bioactivity of the implant should be tested. If the 
cell cultivation tests are promising, experimental study with animals should be 
considered. 
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